Abstract: The invention provides a simple and cost-effective method for preparing particles such as anisotropic semiconductor nanoparticles (e.g. CdS) and devices thereof. The method comprises (i) dispersing at least part of particle-forming reactants in a self-organized medium such as surfactant-aqueous solution system, and (ii) conducting a particle-forming reaction using the particle-forming reactants dispersed in the self-organized medium under shear condition to form the particles. The anisotropic property of the particles is controlled at least partially by the shear condition. The invention may be used to prepare quantum dots in a liquid crystal, and various devices such as nonlinear optics, optoelectronic devices, and solar cells, among others.
Type:
Grant
Filed:
August 25, 2009
Date of Patent:
September 11, 2012
Assignee:
Kent State University
Inventors:
Antal Jakli, Stefanie Taushanoff, Mátyás Molnár, Attila Bóta, Erika Kalman, Peter Palinkás, legal representative, Andrea Palinkás, legal representative, Zoltan Varga
Abstract: A method and apparatus for varying the twist of a wing such that induced drag is minimized or reduced during cruise and lift is maximized or increased at least during takeoff and landings. In addition, variations in the twist may produce yawing and rolling moments. The twist amount is varied pursuant to the operating conditions, including those parameters used to determine the lift coefficient. The twist for reducing induced drag and/or improving lift may be employed by geometric or aerodynamic twist, including full span control surfaces used to provide roll control, high-lift and reduced induced drag. The twist may also be employed by twisting just a portion of the wing or the entire wing, either geometrically or aerodynamically.
Abstract: The invention provides polyanhydrides that degrade in less than 60 hours following topical administration to deliver biologically active compounds.
Type:
Grant
Filed:
May 23, 2006
Date of Patent:
September 11, 2012
Assignee:
Rutgers, The State University of New Jersey
Abstract: The present invention relates to new classes of monomeric compounds, which may be polymerized to form novel biodegradable and bioresorble polymers and copolymers. These polymers and co-polymers, while not limited thereto, may be adapted for radio-opacity and are useful for medical device applications and controlled release therapeutic formulations.
Type:
Application
Filed:
October 11, 2010
Publication date:
September 6, 2012
Applicant:
Rutgers, The State University of New Jersey
Abstract: Fire retardant materials arc provided that contain carbon nanotubes and particles capable of endothermically reacting when exposed to elevated temperatures. The carbon nanotubes may be a buckypaper. Methods also are provided for making a fire retardant material and for improving the fire retardation capabilities of a material.
Type:
Application
Filed:
March 2, 2012
Publication date:
September 6, 2012
Applicant:
FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Inventors:
Changchun Zeng, Chuck Zhang, Ben Wang, Richard Liang, Chase Knight
Abstract: The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the ?-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors.
Type:
Application
Filed:
December 12, 2011
Publication date:
September 6, 2012
Applicant:
The Research Foundation of State University of New York
Inventors:
Li NIU, Zhen HUANG, Hua SHI, John T. LIS
Abstract: Compositions and methods for inhibiting the sprouting of potato tubers are provided. The compositions comprise C3 to C14 aliphatic aldehydes and ketones, and/or C3 to C7 primary and secondary aliphatic alcohols.
Type:
Grant
Filed:
August 6, 2008
Date of Patent:
September 4, 2012
Assignee:
Washington State University Research Foundation
Inventors:
Norman Richard Knowles, Lisa O'Rear Knowles
Abstract: Amphipathic lytic peptides are ideally suited to use in a ligand/cytotoxin combination to specifically inhibit cells that are driven by or are dependent upon a specific ligand interaction; for example, to induce sterility or long-term contraception, or to attack tumor cells, or to selectively lyse virally-infected cells, or to attack lymphocytes responsible for autoimmune diseases. The peptides act directly on cell membranes, and need not be internalized. Administering a combination of gonadotropin-releasing hormone (GnRH) (or a GnRH agonist) and a membrane-active lytic peptide produces long-term contraception or sterilization in animals in vivo. Administering in vivo a combination of a ligand and a membrane-active lytic peptide kills cells with a receptor for the ligand. The compounds are relatively small, and are not antigenic. Lysis of gonadotropes has been observed to be very rapid (on the order of ten minutes.) Lysis of tumor cells is rapid.
Type:
Grant
Filed:
June 19, 2009
Date of Patent:
September 4, 2012
Assignee:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Inventors:
Frederick M. Enright, Jesse M. Jaynes, William Hansel, Kenneth L. Koonce, Samuel M. McCann, Wen H. Yu, Patricia A. Melrose, Lane D. Foil, Philip H. Elzer
Abstract: The present invention provides compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases, for stimulating an immune response in a subject, and for use as an alternative to interleukin-12 (IL-12) treatment. In particular, the present invention provides Apicomplexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of cancer and infectious diseases and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of cancer and/or infectious diseases, for use as an alternative to interleukin-12 (IL-12) treatment, and for eliciting an immune response in a subject, are also provided.
Type:
Grant
Filed:
April 14, 2008
Date of Patent:
September 4, 2012
Assignee:
Michigan State University
Inventors:
Charles Aylsworth, Siu-Cheong Ho, David Juckett, John W. Judge, Barnett Rosenberg, Igor V. Zlatkin, Tatiana Zlatkin
Abstract: A method for treating cancer tumors, particularly ovarian cancer tumors, is described, where fused cyclic pyrimidine having a cancer treating ability is selectively delivered to an FR expressing cancerous tumor.
Type:
Grant
Filed:
June 21, 2007
Date of Patent:
September 4, 2012
Assignees:
Duquesne University of the Holy Ghost, Wayne State University
Abstract: An acceleration-triggered or shock-triggered, smart, tunable MEMS switch that may function as both a classic accelerometer and an acceleration threshold detector. A parallel element MEMS device has a stationary and a movable element forming a capacitor. Varying acceleration moves the movable member with respect to the stationary member, thereby changing the capacitance of the device. The capacitance varying may be used, in cooperation with appropriate circuitry, to provide a signal representative of instantaneous acceleration. By applying a biasing voltage, the movable element may be positioned in a predetermined fashion such that acceleration of a predetermined magnitude causes the movable element to pull in (snap down). The movable and stationary elements may function as a switch such that when the predetermined acceleration or shock level occurs, electrodes close, a current flows between the elements so that an external device such as an air bag may be activated.
Type:
Grant
Filed:
February 13, 2009
Date of Patent:
September 4, 2012
Assignee:
The Research Foundation of State University of New York
Abstract: A process for making a stimuli responsive liquid crystal-polymer composite fiber comprising mixing a liquid crystal, a polymer, and a solvent; processing the mixture in the presence of an electric potential across a collection distance; phase separating a polymer and said liquid crystal; and encapsulating said liquid crystal within said polymer. The fiber generally comprises a liquid crystal core and a polymer shell wherein the liquid crystal is responsive to chemical changes, thermal and mechanical effects, as well as electrical and magnetic fields. A liquid crystal containing fiber can be utilized as optical fibers, in textiles, and in optoelectronic devices.
Type:
Grant
Filed:
September 22, 2009
Date of Patent:
September 4, 2012
Assignee:
Kent State University
Inventors:
Ebru A. Buyuktanir, Margaret W. Frey, John L. West
Abstract: A formulation and method for removing viruses from fresh produce, including at least one surfactant, and a solvent. Preferably, the formulation also includes at least one sanitizer.
Abstract: Methods for synthesizing a methacrylate-derivatized type-I collagen in which methacrylic acid is reacted with a carboxylic acid activating reagent in the presence of a carbodiimide to form a methacrylic acid with an activated carboxylic acid group, which is then reacted with free amino groups on type-I collagen to form a collagen methacrylamide. Methacrylate-derivatized collagen, cross-linked collagens formed therefrom and products containing the cross-linked collagen are also disclosed.
Type:
Application
Filed:
September 29, 2011
Publication date:
August 30, 2012
Applicant:
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Abstract: The present application provides synbodies against AKT1 differing in amino acid sequence, conjugation chemistry, linker/scaffold, or adjunct moiety. The synbodies are useful for diagnosis and treatment of cancer and as research reagents.
Type:
Application
Filed:
March 1, 2012
Publication date:
August 30, 2012
Applicant:
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Inventors:
Stephen A. Johnston, Christopher Diehnelt, Nidhi Gupta, Paul Belcher
Abstract: The present invention provides novel silicon-germanium hydride compounds, methods for their synthesis, methods for their deposition, and semiconductor structures made using the novel compounds.
Type:
Application
Filed:
February 28, 2012
Publication date:
August 30, 2012
Applicant:
The Arizona Board of Regents, a body corporated acting on behalf of Arizona State University
Abstract: A method of modifying the amount of at least one biochemical component in a plant comprising expressing Qua-Quine Starch (QQS) in the plant, the wild-type of which does not express QQS; a transgenic plant, or part thereof, which comprises and expresses QQS as a transgene and in which the amount of at least one biochemical component is modified; a tissue culture of regenerable cells of the transgenic plant; a vector comprising a nucleotide sequence, which encodes the coding sequence of QQS, operably linked to a non-native promoter, which promotes expression of the nucleotide sequence in a plant, which is other than Arabidopsis; and a method of producing a food or industrial product from a plant.
Type:
Application
Filed:
December 7, 2011
Publication date:
August 30, 2012
Applicant:
IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Abstract: A field effect transistor (FET) with a source electrode and a drain electrode distanced apart from each other on a semi-conductor substrate, and a gate electrode consisting of a uniform layer of reduced graphene oxide encapsulated semiconductor nanoparticles (rGO-NPs), wherein the gate electrode is disposed between and contacts both the source and drain electrodes. Methods of making and assay methods using the FETs are also disclosed, including methods in which the rGO-NPs are functionalized with binding partners for biomarkers.
Type:
Application
Filed:
February 17, 2012
Publication date:
August 30, 2012
Applicant:
Rutgers, The State University of New Jersey
Abstract: Provided herein are methods and compositions for the diagnosis, prognosis and treatment of Hepatocellular carcinoma (HCC). Also provided are methods of identifying anti-HCC agents.
Type:
Grant
Filed:
November 1, 2007
Date of Patent:
August 28, 2012
Assignees:
The Ohio State University, The United States of America as represented by the Secretary of the Department of Health and Human Services National Institute of Health, Office of Technology Transfer, Liver Cancer Institute and Zhongshan Hospital, Fudan University
Inventors:
Carlo M. Croce, Xin W. Wang, Anuradha Budhu, Zhao-you Tang